NCT02000687Recruiting
Long Term Surveillance of Islet Transplant Recipients Following Complete Graft Loss
Source: ClinicalTrials.gov · Last updated 23 Mar 2026
Brief summary (registry, in English)
This is a single-center, prospective, open label study in islet transplant recipients following islet graft loss.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 26 Nov 2013
- Start date
- Dec 2008
- Primary completion date
- Dec 2027
- Lead sponsor
- Rodolfo Alejandro
- Diseases
- Type 1 diabetes
- NCT number
- NCT02000687
What you commit to
- Study type: Observational
- Planned participants: 60
- From Dec 2008 to the primary completion date, Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of any solid organ transplant.
Other
- Inability to provide written informed consent.
- Mentally unstable and/or unable to comply with the procedures of the study protocol.
Who the study is looking for
- 1\. History of at least one islet alone transplant (ie islet transplant in the absence of any other organ transplant).
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Diabetes Research Institute Coordinator of this site? Confirm its status | Miami | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.